Amdocs Limited $DOX Shares Acquired by Russell Investments Group Ltd.

Russell Investments Group Ltd. lifted its stake in shares of Amdocs Limited (NASDAQ:DOX) by 11.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 1,112,976 shares of the technology company’s stock after buying an additional 111,800 shares during the quarter. Russell Investments Group Ltd.’s holdings in Amdocs were worth $63,703,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Maryland State Retirement & Pension System grew its position in Amdocs by 23.1% in the 3rd quarter. Maryland State Retirement & Pension System now owns 6,459 shares of the technology company’s stock valued at $369,000 after buying an additional 1,212 shares during the last quarter. Jacobi Capital Management LLC purchased a new position in Amdocs during the 3rd quarter worth $104,000. Illinois Municipal Retirement Fund raised its position in Amdocs by 22.5% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 73,014 shares of the technology company’s stock worth $4,175,000 after buying an additional 13,417 shares during the last quarter. M&G PLC lifted its stake in shares of Amdocs by 1.2% in the 3rd quarter. M&G PLC now owns 266,160 shares of the technology company’s stock worth $15,171,000 after acquiring an additional 3,180 shares during the period. Finally, Kestra Investment Management LLC lifted its stake in shares of Amdocs by 18.8% in the 3rd quarter. Kestra Investment Management LLC now owns 4,932 shares of the technology company’s stock worth $282,000 after acquiring an additional 780 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Price Performance

Shares of DOX traded up $0.68 during trading hours on Friday, reaching $44.79. The company had a trading volume of 2,245,070 shares, compared to its average volume of 2,150,916. The company has a market capitalization of $4.84 billion, a price-to-earnings ratio of 9.59, a PEG ratio of 1.44 and a beta of 0.42. Amdocs Limited has a 12-month low of $39.96 and a 12-month high of $84.95. The firm has a 50 day simple moving average of $57.51 and a 200-day simple moving average of $60.98. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last issued its earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, hitting the consensus estimate of $1.98. Amdocs had a net margin of 10.59% and a return on equity of 20.81%. The company had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.19 billion. During the same period in the prior year, the business posted $1.83 earnings per share. The firm’s revenue for the quarter was up 3.8% compared to the same quarter last year. Research analysts expect that Amdocs Limited will post 5.82 earnings per share for the current year.

Amdocs Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be paid a dividend of $0.5690 per share. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $2.28 annualized dividend and a dividend yield of 5.1%. Amdocs’s payout ratio is 48.82%.

Analyst Ratings Changes

Several analysts have recently weighed in on DOX shares. Weiss Ratings raised shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 23rd. Stifel Nicolaus cut their price target on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating for the company in a report on Wednesday, November 4th. Zacks Research downgraded shares of Amdocs from a “hold” rating to a “strong sell” rating in a research report on Monday, November 9th. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Finally, Oppenheimer lowered Amdocs from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 4th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $69.00.

Insider Transactions at Amdocs

In other news, Director John Anthony Macdonald acquired 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 10th. The stock was purchased at an average cost of $41.63 per share, with a total value of $41,630.00. Following the purchase, the director directly owned 25,189 shares of the company’s stock, valued at approximately $1,048,618.07. This trade represents a 4.13% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Yvette Kanouff acquired 2,400 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The stock was purchased at an average cost of $42.00 per share, with a total value of $100,800.00. Following the completion of the purchase, the director directly owned 26,600 shares in the company, valued at $1,117,200. This represents a 9.92% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 3,534 shares of company stock valued at $147,966 in the last quarter. 15.40% of the stock is currently owned by corporate insiders.

Top Amdocs Stories

These are some of the DOX stories that stood out recently:

• Positive Sentiment: Amdocs is seeking shareholder approval for a 3% quarterly dividend increase, which could bolster its appeal to income-focused investors. Dividend proposal
• Neutral Sentiment: Call-option trading was unusually active, with 2,152 calls purchased—about 430% above the average daily volume. The activity may reflect bullish positioning, but options trading alone does not establish a lasting change in sentiment.
• Negative Sentiment: Insider Shimie Hortig sold 8,997 shares across transactions on November 10 and 11, reducing his holdings. The sales may weigh on sentiment, though he retained a substantial position. SEC filing

Amdocs Profile

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.